OUTSET MEDICAL INC (OM)
US6901451079 - Common Stock
We assign a fundamental rating of 2 out of 10 to OM. OM was compared to 187 industry peers in the Health Care Equipment & Supplies industry. OM has a bad profitability rating. Also its financial health evaluation is rather negative. OM is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year OM has reported negative net income.
In the past year OM has reported a negative cash flow from operations.
OM had negative earnings in each of the past 5 years.
In the past 5 years OM always reported negative operating cash flow.
1.2 Ratios
OM has a Return On Assets of -48.12%. This is in the lower half of the industry: OM underperforms 65.59% of its industry peers.
OM's Return On Equity of -294.71% is on the low side compared to the rest of the industry. OM is outperformed by 82.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -48.12% | ||
| ROE | -294.71% | ||
| ROIC | N/A |
ROA(3y)-41.42%
ROA(5y)-48.12%
ROE(3y)-80.71%
ROE(5y)-99.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OM's Gross Margin of 30.97% is on the low side compared to the rest of the industry. OM is outperformed by 74.73% of its industry peers.
The Profit Margin and Operating Margin are not available for OM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 30.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
OM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OM has more shares outstanding
The number of shares outstanding for OM has been increased compared to 5 years ago.
Compared to 1 year ago, OM has a worse debt to assets ratio.
2.2 Solvency
OM has an Altman-Z score of -5.01. This is a bad value and indicates that OM is not financially healthy and even has some risk of bankruptcy.
OM's Altman-Z score of -5.01 is on the low side compared to the rest of the industry. OM is outperformed by 70.97% of its industry peers.
A Debt/Equity ratio of 4.12 is on the high side and indicates that OM has dependencies on debt financing.
The Debt to Equity ratio of OM (4.12) is worse than 87.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.12 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.01 |
ROIC/WACCN/A
WACC8.13%
2.3 Liquidity
A Current Ratio of 6.49 indicates that OM has no problem at all paying its short term obligations.
OM has a Current ratio of 6.49. This is amongst the best in the industry. OM outperforms 86.02% of its industry peers.
A Quick Ratio of 5.04 indicates that OM has no problem at all paying its short term obligations.
OM has a better Quick ratio (5.04) than 80.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.49 | ||
| Quick Ratio | 5.04 |
3. Growth
3.1 Past
OM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.06%, which is quite impressive.
The Revenue for OM has decreased by -13.01% in the past year. This is quite bad
OM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 130.59% yearly.
EPS 1Y (TTM)40.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.07%
Revenue 1Y (TTM)-13.01%
Revenue growth 3Y37.73%
Revenue growth 5Y130.59%
Sales Q2Q%-5.59%
3.2 Future
The Earnings Per Share is expected to grow by 13.26% on average over the next years. This is quite good.
OM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.97% yearly.
EPS Next Y38.53%
EPS Next 2Y24.76%
EPS Next 3Y17.56%
EPS Next 5Y13.26%
Revenue Next Year-13.85%
Revenue Next 2Y-1.88%
Revenue Next 3Y1.63%
Revenue Next 5Y7.97%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for OM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OM. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as OM's earnings are expected to grow with 17.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.76%
EPS Next 3Y17.56%
5. Dividend
5.1 Amount
No dividends for OM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OUTSET MEDICAL INC
NASDAQ:OM (1/6/2025, 6:11:20 PM)
After market: 1.3 +0.03 (+2.36%)1.27
-0.13 (-9.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners96.45%
Inst Owner Change0%
Ins Owners1.91%
Ins Owner Change-1.02%
Market Cap66.73M
Analysts83.08
Price Target4.08 (221.26%)
Short Float %5.1%
Short Ratio3.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.59%
Min EPS beat(2)-1.03%
Max EPS beat(2)10.2%
EPS beat(4)2
Avg EPS beat(4)3.79%
Min EPS beat(4)-1.03%
Max EPS beat(4)10.2%
EPS beat(8)3
Avg EPS beat(8)-2.21%
EPS beat(12)3
Avg EPS beat(12)-5.23%
EPS beat(16)6
Avg EPS beat(16)-2.15%
Revenue beat(2)1
Avg Revenue beat(2)-5.65%
Min Revenue beat(2)-14.74%
Max Revenue beat(2)3.44%
Revenue beat(4)1
Avg Revenue beat(4)-5.94%
Min Revenue beat(4)-14.74%
Max Revenue beat(4)3.44%
Revenue beat(8)4
Avg Revenue beat(8)-2.92%
Revenue beat(12)6
Avg Revenue beat(12)-2.17%
Revenue beat(16)10
Avg Revenue beat(16)0.27%
PT rev (1m)21.52%
PT rev (3m)10.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-39.88%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-40.77%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)1.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.58 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.4 | ||
| P/tB | 1.4 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.02
EYN/A
EPS(NY)-1.38
Fwd EYN/A
FCF(TTM)-2.4
FCFYN/A
OCF(TTM)-2.37
OCFYN/A
SpS2.18
BVpS0.91
TBVpS0.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -48.12% | ||
| ROE | -294.71% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 30.97% | ||
| FCFM | N/A |
ROA(3y)-41.42%
ROA(5y)-48.12%
ROE(3y)-80.71%
ROE(5y)-99.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.12 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 33.25% | ||
| Cap/Sales | 1.67% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 6.49 | ||
| Quick Ratio | 5.04 | ||
| Altman-Z | -5.01 |
F-Score4
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)93.53%
Cap/Depr(5y)158.24%
Cap/Sales(3y)4.3%
Cap/Sales(5y)10.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.07%
EPS Next Y38.53%
EPS Next 2Y24.76%
EPS Next 3Y17.56%
EPS Next 5Y13.26%
Revenue 1Y (TTM)-13.01%
Revenue growth 3Y37.73%
Revenue growth 5Y130.59%
Sales Q2Q%-5.59%
Revenue Next Year-13.85%
Revenue Next 2Y-1.88%
Revenue Next 3Y1.63%
Revenue Next 5Y7.97%
EBIT growth 1Y25.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.35%
EBIT Next 3Y18.94%
EBIT Next 5Y14.42%
FCF growth 1Y16.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.64%
OCF growth 3YN/A
OCF growth 5YN/A